CCR2 and neoplasm: In tumor regression studies, triple treatment of anti-CCR2 + IR + cGAMP showed superior anti-tumor response compared with treatment with IR alone or IR + cGAMP (Fig. 6b, P < 0.05 for both: Student’s t-test).